Grants and Contracts Details
| Status | Finished |
|---|---|
| Effective start/end date | 2/1/05 → 1/31/07 |
A Phase III Multicenter Open Label Long Term Study of the Safety Tolerablity of Intravenous Natalizumab in Chron's Disease Subjects Who Have Previously Participated in Natalizumab Chron's Disease Study CD35
- De Villiers, Willem (PI)